General Anxiety Disorder Treatment Market Trend, Share, Growth, Size, Analysis and Forecast 2034

General Anxiety Disorder Treatment Market: Industry Prospective

The global general anxiety disorder treatment market size was worth around USD 11.93 Billion in 2024 and is predicted to grow to around USD 17.32 Billion by 2034 with a compound annual growth rate (CAGR) of roughly 3.8% between 2025 and 2034. The report analyzes the global general anxiety disorder treatment market's drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the general anxiety disorder treatment industry.

The study provides an assessment and analysis of the General Anxiety Disorder Treatment Market on a global & regional level. It offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2018 to 2021 along with a forecast from 2022 to 2028 based on revenue (USD Billion).

Request Free Sample

General Anxiety Disorder Treatment Market: Synopsis

General Anxiety Disorder is a mental health ailment producing fear, worry, and a consistent feeling of getting overwhelmed. Apart from this, it features excess, constant, and unrealistic worry about routine activities among individuals. Moreover, the worry can be of health issues, family, and financial matters. According to NCBI, nearly twenty percent of adults suffer from this disorder each year. Reportedly, a general anxiety disorder can have physical as well as emotional effects on a person. An individual suffering from general anxiety disorder possesses unrealistic & exaggerated fears or imaginary fears which are not connected with anything concrete or associated with any such fearsome situation. Moreover, an individual can feel anxious about anything and this is referred to as generalized or general anxiety. It has been found the syndrome or disorder is detected in persons who had suffered from some kind of trauma in childhood, lived through a hard period or suffered losses, and undergo extreme work stress or family problems.

According to NCBI, general anxiety disorder is a common kind of anxiety ailment found both in men and women. Moreover, it is generally found in elderly or middle-aged persons as well as in children. The condition is less common in persons over sixty-five years old. There are different ways of treating this disorder and it includes psychological therapy such as cognitive behavioral treatment, intake of medicines such as anti-depressants, relaxation techniques including meditation, and getting involved in self-help groups.

General anxiety disorder (GAD) is characterized by constant and excessive worrying which is hard to control and lead to considerable impairment or distress. Other psychological symptoms of anxiety include irritability and apprehensiveness, and physical symptoms of anxiety are increased muscular tension and fatigue. Effective treatments for general anxiety disorder are medications and psychotherapy. Psychotherapy includes applied relaxation and cognitive-behavioral therapy among others.

Key Insights

• As per the analysis shared by our research analyst, the global general anxiety disorder treatment market is estimated to grow annually at a CAGR of around 3.8% over the forecast period (2025-2034).
• Regarding revenue, the global general anxiety disorder treatment market size was valued at around USD 11.93 Billion in 2024 and is projected to reach USD 17.32 Billion by 2034.
• The general anxiety disorder treatment market is projected to grow at a significant rate due to rising prevalence of anxiety disorders, increased mental health awareness, advancements in pharmacological and therapeutic treatments, growing stress levels, and expanding healthcare access.
• Based on Drug Class, the Antidepressants segment is expected to lead the global market.
• On the basis of Indication, the General Anxiety segment is growing at a high rate and will continue to dominate the global market.
• Based on the Distribution Channel, the Hospital Pharmacy segment is projected to swipe the largest market share.
• Based on region, North America is predicted to dominate the global market during the forecast period.

Request Free Sample

General Anxiety Disorder Treatment Market: Growth Drivers

The massive growth of the general anxiety disorder treatment industry over the next few years can be attributed to rising in work stress & hectic lifestyle. In addition to this, the rise in the production of medicines for treating general anxiety disorder will open new growth dimensions for the general anxiety disorder treatment market. Furthermore, massive use of psychotherapy and treating patients with psychoactive medicines are few of the effective therapeutic solutions for general anxiety disorder. Moreover, the rise in incidences of general anxiety disorders can be attributed to heredity, stressful event, and brain chemistry. A rise in awareness about mental disorders, early diagnosis of these disorders, and awareness among people about the need for treating them immediately will drive market trends. However, the lack of availability of any specific diagnostics tests for determining general anxiety disorder and its treatment can deter the growth of the general anxiety disorder treatment market. Apart from this, nausea and dry mouth are the side effects associated with the intake of medicines and this can pose a barrier to market expansion.

General Anxiety Disorder Treatment Market: Report Scope    

General Anxiety Disorder Treatment Market: Regional Landscape

North America General Anxiety Disorder Treatment Market To Witness Exponential Growth By 2028

Regional dominance of North America over forthcoming years can be due to factors such as a rise in cases of general anxiety among the workforce in countries such as the U.S. due to long working hours and hectic & irregular lifestyles. Apart from this, the presence of key players in the sub-continent will contribute sumptuously toward the regional market surge.

General Anxiety Disorder Treatment Market: Competitive Insights

The report provides a company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market, including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the general anxiety disorder treatment market on a global and regional basis.

• Pfizer
• Merck & Co. Inc.
• AstraZeneca
• GlaxoSmithKline plc
• Eli Lilly and Company
• Bristol-Myers Squibb
• Johnson & Johnson
• H. Lundbeck A/S.

The global General Anxiety Disorder Treatment Market is segmented as follows:

By Drug Class

• Antidepressants
• Benzodiazepines
• Buspirone

By Indication

• General Anxiety
• Depression

By Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America